Predicting hepatotoxicity using cell based assays
First Claim
Patent Images
1. A method of assessing the hepatotoxicity of a stimulus, the method comprising:
- (a) exposing a hepatocyte culture to the stimulus;
(b) imaging the hepatocytes with an optical image acquisition system configured to capture digital images;
(c) analyzing a digital image of the hepatocytes to extract features characterizing the hepatocytes by executing instructions on a computer system;
(d) classifying the stimulus by quantitatively evaluating the extracted features to identify one or more hepatotoxic pathologies resulting from the stimulus by executing instructions on a computer system, wherein hepatotoxic pathology classifications include two or more of the following;
necrosis, cholestasis, steatosis, fibrosis, apoptosis, and cirrhosis; and
(e) displaying the one or more hepatotoxic pathology classifications on a display.
0 Assignments
0 Petitions
Accused Products
Abstract
Cell based assays are used to assess the hepatotoxicity of a stimulus. Imaging technologies are used to analyze the effects of a stimulus on hepatocytes. Image analysis may characterize the stimulus on the basis of whether it is hepatotoxic, and if so what type of pathology is exhibited; e.g., apoptosis, necrosis, cholestasis, and/or steatosis.
70 Citations
19 Claims
-
1. A method of assessing the hepatotoxicity of a stimulus, the method comprising:
-
(a) exposing a hepatocyte culture to the stimulus; (b) imaging the hepatocytes with an optical image acquisition system configured to capture digital images; (c) analyzing a digital image of the hepatocytes to extract features characterizing the hepatocytes by executing instructions on a computer system; (d) classifying the stimulus by quantitatively evaluating the extracted features to identify one or more hepatotoxic pathologies resulting from the stimulus by executing instructions on a computer system, wherein hepatotoxic pathology classifications include two or more of the following;
necrosis, cholestasis, steatosis, fibrosis, apoptosis, and cirrhosis; and(e) displaying the one or more hepatotoxic pathology classifications on a display. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
Specification